Symbol
ANRO on NYSE
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
1.62M shares
Security Ownership
5.6%

K2 HealthVentures Equity Trust LLC ownership in Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO)

2025-05-15 - K2 HealthVentures Equity Trust LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.62M shares of Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO). This represents 5.6% percent ownership of the company.